UROTHELIAL CANCER
Clinical trials for UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New clip aims for firmer grip in robotic cancer operations
Disease control CompletedThis study tested a new type of surgical clip designed to better seal blood vessels during robotic surgery for prostate, kidney, or bladder cancer. Forty patients were randomly assigned to receive either the new VasoClip or a standard clip during their operation. The main goal wa…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE3 • Sponsor: Incheon St.Mary's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Real-World cancer care: which drug works better after chemo?
Disease control CompletedThis study looked at how well two different immunotherapy drugs work for people with advanced bladder cancer who had already received chemotherapy. Researchers followed 35 patients in real-world hospital settings to compare Avelumab (given right after chemo) and Pembrolizumab (gi…
Matched conditions: UROTHELIAL CANCER
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Real-World data sheds light on bladder cancer treatment
Disease control CompletedThis study observed how well the drug Avelumab worked in real-world settings for adults with advanced bladder cancer. It included 106 patients whose cancer had not worsened after initial chemotherapy and who then received Avelumab as a standard maintenance therapy. The goal was t…
Matched conditions: UROTHELIAL CANCER
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug shows promise for Tough-to-Treat advanced bladder cancer
Disease control CompletedThis study tested whether a new drug called enfortumab vedotin helped people with advanced bladder cancer live longer than standard chemotherapy. It involved 608 adults whose cancer had spread or returned after previous treatments with immunotherapy and platinum-based chemotherap…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC